RECRUITINGOBSERVATIONAL
2177GCCC:ID'Ing tx Targets and Biomarkers for Ocular Surface Disease in Pt w/ oGVHD
2177GCCC: Identifying Novel Treatment Targets and Biomarkers for Ocular Surface Disease in Patients With Ocular Graft vs Host Disease (oGVHD) a Biobank Study
About This Trial
Evaluate and study the immunologic changes to the ocular surface in cancer patients.
Who May Be Eligible (Plain English)
Who May Qualify:
- Adult patients (≥ 18 years of age) who visit the Eye clinic either in the UMGCCC within the UMD Hospital or the UMD Faculty Physicians Ophthalmology Practice at the UMD Professional Building or satellite locations for initial visits or established visits.
- The patient must be able to understand and sign and date the willing to sign a consent form form approved by the IRB.
Who Should NOT Join This Trial:
- Vulnerable populations: neonates, children, prisoners, institutionalized individuals.
- Inability or refusal to provide willing to sign a consent form.
- History of ocular surgery (except refractive surgery or cataract surgery)
Always talk to your doctor about whether this trial is right for you.
Original Eligibility Criteria
View original clinical language
Inclusion Criteria:
* Adult patients (≥ 18 years of age) who visit the Eye clinic either in the UMGCCC within the UMD Hospital or the UMD Faculty Physicians Ophthalmology Practice at the UMD Professional Building or satellite locations for initial visits or established visits.
* The patient must be able to understand and sign and date the informed consent form approved by the IRB.
Exclusion Criteria:
* Vulnerable populations: neonates, children, prisoners, institutionalized individuals.
* Inability or refusal to provide informed consent.
* History of ocular surgery (except refractive surgery or cataract surgery)
Treatments Being Tested
DIAGNOSTIC_TEST
The standard care exam and biological specimens' collection
During each visit, in addition to standard of care exams, certain biological specimens ( ocular surface wash, mucocellular material, corneal filaments or impression cytology of conjunctiva, blood or serum) will be collected.
Locations (1)
Geenebaum Cancer Center, University of Maryland Medical Center
Baltimore, Maryland, United States